Physician profile
Andrew Nash
NPI 1518997402
$1,890.79
in general payments reported to CMS, 2019-2025
17 companies · $209 in 2025
The $209 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $130 · 2021: $228 · 2022: $409 · 2023: $458 · 2024: $261 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $257.64 | 2019-2025 | Bexsero, Penmenvy, Shingrix |
| Corium, LLC | $244.14 | 2022-2023 | Azstarys |
| Pfizer INC. | $202.24 | 2019-2023 | |
| Kaleo, INC. | $181.43 | 2023-2024 | Auvi-Q |
| Genzyme Corporation | $151.95 | 2023 | |
| Cranial Technologies, INC | $136.72 | 2020-2025 | Doc Band |
| Tris Pharma INC | $124.43 | 2019-2024 | Dyanavel Xr |
| Astrazeneca Pharmaceuticals Lp | $113.10 | 2021-2023 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $100.86 | 2022-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Adlon Therapeutics L.P. | $67.84 | 2019-2021 | |
| Sanofi Pasteur INC. | $62.22 | 2021-2024 | |
| Sobi, INC | $56.60 | 2019 | |
| Acadia Pharmaceuticals INC | $51.80 | 2023-2025 | Daybue |
| Neos Therapeutics, Lp | $40.29 | 2019 | |
| Ironshore Pharmaceuticals INC. | $37.82 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $32.80 | 2025 | Zoryve |
| Abbvie INC. | $28.91 | 2019-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.